Riyad Adnan Almaimani (Riyad A Almaimani)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Pharmaceutics

Life (Basel, Switzerland)

International journal of molecular sciences

Cancers

Umm Al-Qura University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Umm Al-Qura University Jul 01 2008

Saudi Arabia

Assisstant professor :: Biochemsitry

Publications

Ammar Bader, Ashraf N Abdalla, Najla A Obaid, Lamees Youssef, Hind M Naffadi, Mohamed Elzubier Elzubier, Riyad Adnan Almaimani, Maria Flamini Hatem Ciudad-Mulero, Ylenia Pieracci, Mahmoud Zaki El-Readi
In Vitro Anticancer and Antibacterial Activities of the Essential Oil of Forsskal's Basil Growing in Extreme Environmental Conditions. Life (Basel, Switzerland) 13 (3) (2023)
Rania Moataz El-Dahmy, Ibrahim Elsayed, Jihan Hussein, Mohammad Althubiti, Riyad Adnan Almaimani, Mahmoud Zaki El-Readi, Marawan A Elbaset, Bassant M M Ibrahim
Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation. Pharmaceutics 15 (4) (2023)
Maimonah Fuad Koshak, Mahmoud Zaki El-Readi, Mohamed Elzubier Elzubier, Bassem Refaat, Riyad Adnan Almaimani, Shakir Idris, Mohammad A Althubiti, Hiba Saeed Al-Amodi, Safaa Yehia Eid
Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats. Marine drugs 21 (11) (2023)
Ammar Bader, Ashraf N Abdalla, Najla A Obaid, Lamees Youssef, Hind M Naffadi, Mohamed Elzubier Elzubier, Riyad Adnan Almaimani, Maria Flamini Hatem Ciudad-Mulero, Ylenia Pieracci, Mahmoud Zaki El-Readi
In Vitro Anticancer and Antibacterial Activities of the Essential Oil of Forsskal's Basil Growing in Extreme Environmental Conditions. Life (Basel, Switzerland) 13 (3) (2023)
Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid, Anmar A Khan, Riyad Adnan Almaimani, Shakir Idris, Mohamed Elzubier Elzubier, Elshiekh Babiker A Khidir, Akhmed Aslam, Faisal Minshawi, Mohammad A Alobaidy, Adel B Alharbi, Hussain A Almasmoum, Mazen Ghaith, Khalid M Alquthami, Bassem Refaat
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International journal of molecular sciences 24 (24) (2023)
Ammar Bader, Ashraf N Abdalla, Najla A Obaid, Lamees Youssef, Hind M Naffadi, Mohamed Elzubier Elzubier, Riyad Adnan Almaimani, Maria Flamini Hatem Ciudad-Mulero, Ylenia Pieracci, Mahmoud Zaki El-Readi
In Vitro Anticancer and Antibacterial Activities of the Essential Oil of Forsskal's Basil Growing in Extreme Environmental Conditions. Life (Basel, Switzerland) 13 (3) (2023)
Rania Moataz El-Dahmy, Ibrahim Elsayed, Jihan Hussein, Mohammad Althubiti, Riyad Adnan Almaimani, Mahmoud Zaki El-Readi, Marawan A Elbaset, Bassant M M Ibrahim
Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation. Pharmaceutics 15 (4) (2023)
Rania Moataz El-Dahmy, Ibrahim Elsayed, Jihan Hussein, Mohammad Althubiti, Riyad Adnan Almaimani, Mahmoud Zaki El-Readi, Marawan A Elbaset, Bassant M M Ibrahim
Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation. Pharmaceutics 15 (4) (2023)
Rania Moataz El-Dahmy, Ibrahim Elsayed, Jihan Hussein, Mohammad Althubiti, Riyad Adnan Almaimani, Mahmoud Zaki El-Readi, Marawan A Elbaset, Bassant M M Ibrahim
Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation. Pharmaceutics 15 (4) (2023)
Manar G Salem, Sara A Abu El-Ata, Elsherbiny H Elsayed, Suraj Narayan Mali, Hussah Abdullah Alshwyeh, Ghassan Almaimani, Riyad Adnan Almaimani, Hussain A Almasmoum, Najla A Altwaijry, Ebtesam Al-Olayan, Essa M Saied, Mohamed F Youssef
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity. RSC advances 13 (47) (2023)
Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid, Anmar A Khan, Riyad Adnan Almaimani, Shakir Idris, Mohamed Elzubier Elzubier, Elshiekh Babiker A Khidir, Akhmed Aslam, Faisal Minshawi, Mohammad A Alobaidy, Adel B Alharbi, Hussain A Almasmoum, Mazen Ghaith, Khalid M Alquthami, Bassem Refaat
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International journal of molecular sciences 24 (24) (2023)
Riyad Adnan Almaimani, Akhmed Aslam, Jawwad Ahmad, Mahmoud Zaki El-Readi, Mohamed E El-Boshy, Abdelghany H Abdelghany, Shakir Idris, Mai Alhadrami, Mohammad Althubiti, Hussain A Almasmoum, Mazen M Ghaith, Mohamed E Elzubeir, Safaa Yehia Eid, Bassem Refaat
In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D 3 , and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network. Cancers 14 (6) (2022)
Hongmin Chen, Xiaojie Feng, Ling Gao, Suresh Mickymaray, Anand Paramasivam, Faiz Abdulaziz Alfaiz, Hussain A Almasmoum, Mazen M Ghaith, Riyad Adnan Almaimani, Ibrahim Abdel Aziz Ibrahim
Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells. Artificial cells, nanomedicine, and biotechnology 49 (1) (2021)
Mazen M Ghaith, Mohammad Abdul Majeed Mohammad Aref Al Banghali, Abdullah F Aldairi, Mohammad S Iqbal, Riyad Adnan Almaimani, Khalid AlQuthami, Mansour H Alqasmi, Wail Almaimani, Mahmoud Zaki El-Readi, Ahmad Alghamdi, Hussain A Almasmoum
Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2021 (2021)
Mohamed E Abdallah, Mahmoud Zaki El-Readi, Mohammad Ahmad Althubiti, Riyad Adnan Almaimani, Amar Mohamed Ismail, Shakir Idris, Bassem Refaat, Waleed Hassan Almalki, Abdullatif Taha Babakr, Mohammed H Mukhtar, Ashraf N Abdalla, Omer Fadul Idris
Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules (Basel, Switzerland) 25 (15) (2020)

Riyad Adnan Almaimani.css-eqlu8i{font-size:small;padding-left:4px;} (Riyad A Almaimani)

Publication Activity (10 Years)

Top Topics

Top Venues

Riyad Adnan Almaimani (Riyad A Almaimani)